Medindia
Medindia LOGIN REGISTER
Advertisement

AMILPAR - Press Release - Acquisition of Lincx

Thursday, May 26, 2011 General News
Advertisement
RIO DE JANEIRO, May 25, 2011 /PRNewswire/ -- AMIL PARTICIPACOES S.A. (BM&FBovespa: AMIL3; Bloomberg: AMIL3 BZ; Reuters: AMIL3 SA), the largest healthcare operator in Brazil, informs that signed today through its subsidiary Amil Assistencia Medica Internacional S.A. ("Amil"), a Purchase Agreement with the controlling shareholders of Lincx Sistemas de Saude Ltda. ("Lincx") for the acquisition and transference of up to 100% of their interest in that company.
Advertisement

The amount to be paid for the acquisition, subject to confirmation after the auditing process, is R$ 170 million and should be made in 4 installments. Lincx has approximately R$ 20 million in cash, which will be part of the assets acquired – reducing the Equity Value to roughly R$ 150 million – and has no financial debt.
Advertisement

Lincx annualized revenues in 2011 are close to R$ 220 million with an EBITDA margin of approximately 8% (without synergies). The company has a portfolio with 36,000 members, 30,000 of which in health plans (being approximately 76% of corporate clients) and 6,000 in dental plans, operates mainly in the state of Sao Paulo, with branches in Londrina (state of Parana) and Rio de Janeiro, in the Premium segment – focused in high income clients – for 18 years.

Before this acquisition, AMILPAR already served the high income segment through its own brand AMIL ONE, launched in 2010, and now our presence in this market will increase significantly. It is important to highlight that all contracts previously undertaken by Lincx will be respected and that, from now on, all Lincx's stakeholders, specially doctors and beneficiaries, will count with even more solidity for being with the largest private healthcare company in Brazil.

The effectiveness of this acquisition is subject to the approval of the Brazilian Healthcare Agency - ANS ("Suspensive Condition"). This deal will also be submitted to the analysis of the Brazilian System of Competition Defense (CADE).

To access the .pdf full version of the document, visit our website at www.amilpar.com.br/ir

IR CONTACTErwin KleuserInvestor Relations OfficerPhone: +55 (21) [email protected]www.amilpar.com.br/ir

ABOUT AMILPAR

AMIL PARTICIPACOES S.A. is the largest healthcare operator in Brazil, according to the ANS, currently assisting over 5.5 million members in the states of Sao Paulo, Rio de Janeiro, Parana, Minas Gerais, Pernambuco, Bahia, Rio Grande do Norte and in Distrito Federal.

SOURCE AMILPAR

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close